Virtus LifeSci Biotech Clinical Trials ETF
19 hedge funds and large institutions have $11.4M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.
Holders
19
Holders Change
-2
Holders Change %
-9.52%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
